GGrantIndex
Sort

85,873 grants matching alzheimers

MOLECULAR SUBSTRATES OF AGING AND NEURON DEATH

$1,479,903
University Of Pennsylvania · P01 · FY2001 · AG

Clinical/Imaging Core

$1,479,577
Sandra Weintraub · Northwestern University At Chicago · U19 · FY2022 · AG

Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo Diagnostics

$1,479,548
Kristen Dams-O'Connor · Icahn School Of Medicine At Mount Sinai · U01 · FY2017 · NS

URBAn Native Elders (URBANE): Risk and Protective Factors for Alzheimer's and Related Dementias

$1,479,522
Lonnie A. Nelson · Washington State University · R01 · FY2024 · AG

Medicinal Chemistry Core

$1,479,035
Robert H Mach · University Of Pennsylvania · U19 · FY2019 · NS

A Caribbean Project for Clinical and Basic Neuroscience Research

$1,479,021
Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · U54 · FY2008 · NS

Cellular/Molecular Pathophysiology of Intellectual and Developmental Disabilities

$1,478,549
Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2012 · HD

Decoding and Selective Modulation of Human Memory During Awake/Sleep Cycles

$1,478,534
Itzhak Fried · University Of California Los Angeles · U01 · FY2021 · NS

Caregivers' Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEAS

$1,477,797
Vincent Mor · Brown University · R56 · FY2016 · AG

The Mechanisms of Alterations in Sleep with Age

$1,477,789
Allan Ian Pack · University Of Pennsylvania · P01 · FY2007 · AG

Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP

$1,477,591
Thomas C Neylan · University Of California, San Francisco · R01 · FY2024 · AG

A National Resource for Postmortem Brain Research

$1,477,291
Francine M. Benes · Mclean Hospital · R24 · FY2009 · MH

Central Autonomic Control, Aging and Oxidative Stress

$1,476,897
Howard University · U54 · FY2005 · NS

CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimer’s Disease

$1,476,501
Stephen Mark Rao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AG

Alzheimers Disease Patient Registry

$1,476,438
Ronald C Petersen · Mayo Clinic Rochester · U01 · FY2009 · AG

Genetic models of sporadic Alzheimers Disease in the marmoset

$1,476,351
Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2023 · AG

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

$1,476,033
Daniel Woo · University Of Cincinnati · U01 · FY2020 · NS

Targeting tau for the development of novel Alzheimer's disease therapeutics

$1,475,961
Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2020 · AG

Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment

$1,475,773
D. Martin Watterson · Northwestern University At Chicago · U01 · FY2020 · AG

Geriatric Emergency care Applied Research network 2.0 – Advancing Dementia Care

$1,475,648
Ula Y Hwang · New York University School Of Medicine · R33 · FY2024 · AG

THE IMPACT OF PERK ON POSTTRAUMATIC TAUOPATHY IN ALZHEIMER'S DISEASE

$1,475,548
University Of Kentucky Research Foundation, The · · FY2015 · Department of the Army

ALZHEIMER'S DISEASE RESEARCH CENTER

$1,475,484
University Of Kentucky · P50 · FY2002 · AG

DETECT-AD: Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer's Disease

$1,474,986
Jeffrey A Kaye · Oregon Health & Science University · R56 · FY2021 · AG

The impact of metals and polygenic risk on multiomics, brain aging, and ADRD outcomes

$1,474,042
Justin Adam Colacino · University Of Michigan At Ann Arbor · U01 · FY2024 · AG

Impact of Depression on Alzheimer's disease: Prenatal Immune Origins and Shared Impact of Sex

$1,473,039
Jill M Goldstein · Massachusetts General Hospital · R01 · FY2021 · AG